Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXE5W4
|
||||
| Drug Name |
(3-(2-Fluoroethoxy)-2-methoxyphenyl)-(1-(2-p-toluylphenylethyl)-piperidine-4-yl)-methanol
|
||||
| Synonyms |
CHEMBL476839
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C24H32FNO3
|
||||
| Canonical SMILES |
COc1c(OCCF)cccc1C(O)C2CCN(CCc3ccc(C)cc3)CC2
|
||||
| InChI |
InChI=1S/C24H32FNO3/c1-18-6-8-19(9-7-18)10-14-26-15-11-20(12-16-26)23(27)21-4-3-5-22(24(21)28-2)29-17-13-25/h3-9,20,23,27H,10-17H2,1-2H3
|
||||
| InChIKey |
MJKRYUCQHJLOIV-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1B receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.